Our Programs

Peer Navigation Program

Our Peer Navigation Program matches cancer survivors, people at high risk and their caregivers to trained peer navigator volunteers for phone support and provides a free resource guide personalized for their situation.

Toll-free Helpline

Trained peer volunteers return calls made to our toll free helpline within 48 hours. Helpline support is available in English and Spanish. Callers can also leave a message on a dedicated extension for a board-certified genetic counselor who will return their call and answer general questions about genetics. Call 1-866-288-RISK (7475).

Support Meetings

General support and community specific meetings (Deaf/Hard of Hearing, Caregivers/Parents, People who speak Espanol, LGBTQIA+, Lynch Syndrome, Men, People of Color, Previvors, Survivors, Young Previvors and Young Survivors) led by volunteers connect individuals to other peers and share important resources and information. Meetings are a great opportunity to ask questions and share stories. 

Message Boards

FORCE message boards and private Facebook group are forums where peers can meet and discuss their situations online 24/7 with other people who have faced similar hereditary cancer concerns.

Joining FORCEs Conference

The Joining FORCEs Conference is the largest annual gathering for people affected by hereditary cancer. Attendees include cancer survivors, people in treatment, people with an inherited mutation or family history of cancer, as well as health care providers and caregivers.

XRAY - Reviews of Cancer Research

Our XRAY program provides reliable information on cancer research and related topics. We look behind the headlines and translate the science into plain language to help people make informed decisions.

Information

Our expert-reviewed database has over 200 pages of information on hereditary cancer.

Free Brochure Distribution

FORCE distributes thousands of educational brochures to healthcare providers, hospitals and individuals every year. View, print or order copies in English or Spanish.

Research Recruitment

Our Research Search and Enroll Tool matches people with the research studies for which they qualify. Our targeted research recruitment efforts link participants who are the backbone of clinical research to studies enrolling patients. These efforts accelerate critical hereditary cancer research to improve options and health outcomes for our community.

FORCE Research Advocate Training (FRAT) Program

The FORCE Research Advocate Training program is an online course that prepares consumers to assist researchers in designing relevant and patient-centered research studies on behalf of the hereditary cancer community. The program consists of an expert-led webinar series, supplemental learning, resources and more.

Legislative & Regulatory Advocacy

FORCE is the only national nonprofit advocating for the unique needs of people with or at increased risk of hereditary cancers. We spearhead and influence public policies to ensure that the voice of our community is represented.

National Screening & Prevention Guidelines

We work with medical societies and guideline committees to assure that screening and prevention guidelines are created or updated to reflect the needs of those affected by hereditary cancer.

Insurance Coverage & Access to Care

Coverage and reimbursement for medical care in the U.S. varies based on type of insurance, national guidelines and federal or state laws. We have unparalleled knowledge of how these influence access to care and strive to improve coverage for the hereditary cancer community.

Genetic Privacy & Protections

Individuals affected by hereditary cancer are often concerned about how genetic information can be accessed or used. FORCE was a key player in the passage of GINA and is advocating for more comprehensive genetic protections.

Medical Device Safety & Drug Development

People at increased risk of cancer require a myriad of screening and preventive services; those with hereditary cancer may need different or targeted treatments. FORCE works with federal agencies, researchers, the biopharmaceutical industry and labs to foster safe, accurate and effective medical products.